ascopubs.org

Neoadjuvant (neoadj) osimertinib (osi) ± chemotherapy (CT) vs CT alone in resectable (R) epidermal growth factor receptor-mutated (EGFRm) NSCLC: NeoADAURA.

Epidemiology of plasma cell leukemia in the U.S.: Incidence, mortality and survival predictors. Lung cancer diagnosis rates (LCDR) in lung cancer screening (LCS) and incidental pulmonary nodule (IPN) ...
ascopubs.org

Osimertinib (osi) after definitive chemoradiotherapy (CRT) in patients (pts) with unresectable stage (stg) III epidermal growth factor receptor-mutated (EGFRm) NSCLC: Primary ...

Comparative effectiveness trial of early palliative care delivered via telehealth versus in person among patients with advanced lung cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Annual ...